The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm

European Journal of Vascular and Endovascular Surgery

Volumn 26, Issue 2, 2003, Pages 221-222

  Wahlgren, C M ^a   Swedenborg, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; PROTAMINE SULFATE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ABDOMINAL AORTA ANEURYSM; ADULT; ANEURYSM SURGERY; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE CONCENTRATE; GENERAL CONDITION IMPROVEMENT; HEMODYNAMICS; HEMOSTASIS; HUMAN; KIDNEY FAILURE; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RESPIRATORY FAILURE; SURGICAL TECHNIQUE; THROMBOCYTE;

EID: 0041666596     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.2002.1887     Document Type: Article

References (13)

1. Hedner U. Recombinant factor VIIa (Novoseven) as a hemostatic agent. Semin Hematol 2001; 38(12): 43-47.
2. Kristensen J, Killander A, Hippe E, Helleberg C, Ellegard J, Holm M, Kutti J, Mellqvist UH, Johansson JE, Glazer S, Hedner U. Clinical experience with recombinant factor VIIa in patients with thrombocytopenia. Haemostasis 1996; 26(1): 159-164.
3. Poon M, Demers C, Jobin F, Wu J. Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia. Blood 1999; 94: 3951-3953.
4. Moscardo F, Pérez F, de la Rubia J, Balerdi B, Lorenzo J, Senet M, Aznar I, Carceller S, Sanz M. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. Br J Haematol 2001; 114: 174.
5. Martinowitz U, Kenet G, Segal E, Luboshitz J, Lubetsky A, Ingeslev J, Lynn M. Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51: 431-438.
6. Hendriks H, van der Maaten J, de Wolf J, Waterbolk T, Sloof M, van der Meer J. An effective treatment of intractable bleeding after valve repair by one single dose of activated recombinant factor VII. Anesth Analg 2001; 93: 287-289.
7. Hendriks H, Meijer K, de Wolf J, Klompmaker I, Porte R, de Kam P, Hagenaars A, Melsen T, Slooff M, van der Meer J. Reduced transfusion requirements by recombinant factor VII in orthotopic liver transplantation: a pilot study. Transplantation 2001; 71: 402-405.
8. Gerlach R, Marquardt G, Wissing H, Scharrer I, Raabe A, Seifert V. Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. J Neurosurg 2002; 96: 946-948.
9. Nypaver T, Shepard A, Reddy D, Elliott J, Smith R, Ernst C. Repair of pararenal abdominal aortic aneurysms: An analysis of operative management. Arch surg 1993; 128: 803-811.
10. Gerler J, Cambria R, Brewster D, Davison J, Purcell P, Zannetti S, Johnson S, L'Italien G, Koustas G, Lamuraglia G, Laposata M, Abbot W. Coagulation changes during thoracoabdominal aneurysm repair. J Vasc Surg 1996; 24: 936-943.
11. Hoffman M, Monroe D, Roberts H. Activated factor VII activates factor IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII. Blood Coagul Fibrinolysis 1998; 9(1): S61-S65.
12. Chuansumrit A, Nuntnarumit P, Okascharoen C, Teeraratkul S, Suwansingh S, Supapannachart S. The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy. Pediatrics 2002; 110: 169-171.
13. Roberts H. Recombinant factor VIIa (Novoseven) and the safety of treatment. Semin Hematol 2001; 38(12): 48-50.